WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Ownership - Who owns Ocular Therapeutix?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ocular Therapeutix Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Summer Road LLC10% Owner2024-02-26930,851$7.52
$7.00MBuy
Antony C. MattessichPresident and CEO2024-02-0519,642$4.86
$95.46kSell
Christopher G. WhiteChief Business Officer2024-02-055,910$4.86
$28.72kSell
Donald NotmanChief Financial Officer2024-02-056,212$4.86
$30.19kSell
Rabia Gurses OzdenChief Medical Officer2024-02-056,346$4.86
$30.84kSell
Philip C. StrassburgerGeneral Counsel2024-02-056,029$4.86
$29.30kSell
Donald NotmanChief Financial Officer2024-01-316,433$4.95
$31.84kSell
Christopher G. WhiteChief Business Officer2024-01-315,147$4.95
$25.48kSell
Philip C. StrassburgerGeneral Counsel2024-01-316,831$4.95
$33.81kSell
Antony C. MattessichPresident and CEO2024-01-3118,338$4.95
$90.77kSell

1 of 2

OCUL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCUL insiders and whales buy or sell their stock.

OCUL Shareholders

What type of owners hold Ocular Therapeutix Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Opaleye Management Inc6.87%10,213,500$51.07MInsider
Deep Track Capital LP6.21%9,230,769$46.15MInstitution
Summer Road LLC5.78%8,591,401$42.96MInsider
Vr Adviser LLC5.23%7,775,760$38.88MInstitution
Summer Road LLC5.15%7,660,550$38.30MInstitution
Opaleye Management Inc4.08%6,070,000$30.35MInstitution
Blackrock Inc3.88%5,761,533$28.81MInstitution
Vanguard Group Inc3.44%5,118,102$25.59MInstitution
Svlsf Iv LLC3.27%4,859,298$24.30MInsider
Franklin Resources Inc3.03%4,500,159$22.50MInstitution

1 of 3

OCUL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCUL49.43%21.84%Net BuyingNet Buying
COGT87.38%11.29%Net BuyingNet Buying
PRAX40.09%59.91%Net BuyingNet Selling
NRIX84.44%15.56%Net SellingNet Selling
IRON44.57%55.43%Net SellingNet Selling
View Top Biotech Stocks

Ocular Therapeutix Stock Ownership FAQ

Who owns Ocular Therapeutix?

Ocular Therapeutix (NASDAQ: OCUL) is owned by 49.43% institutional shareholders, 21.84% Ocular Therapeutix insiders, and 28.73% retail investors. Opaleye Management Inc is the largest individual Ocular Therapeutix shareholder, owning 10.21M shares representing 6.87% of the company. Opaleye Management Inc's Ocular Therapeutix shares are currently valued at $47.44M.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.